Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies.
Thomas SteuberPierre TennstedtAnnalisa MacagnoAlcibiade AthanasiouAnja WittigRamy HuberBruno GoldingRalph SchiessSilke GillessenPublished in: BJU international (2018)
A model combining two cancer-related glycoproteins (THBS1 and CTSD) and %fPSA can improve PCa diagnosis and may reduce the number of unnecessary prostate biopsies because of its improved specificity for PCa when compared to %fPSA alone.